Koers CaliPharms, Inc. Other OTC
Aandelen
KGET
US4984561021
Farmaceutische producten
Omzet 2012 | - | Omzet 2013 | - | Marktkapitalisatie | 8,23 mln. 7,69 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2012 | - 0 | Nettowinst (verlies) 2013 | - 0 | EV/omzet 2012 * | - |
Nettoschuld 2012 | 617K 576K | Nettoschuld 2013 | 667K 623K | EV/omzet 2013 | - |
K/w-verhouding 2012 * |
-
| K/w-verhouding 2013 |
-0,51
x | Werknemers | - |
Dividendrendement 2012 * |
-
| Dividendrendement 2013 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,81% | 5,82 mld. | |
-25,27% | 3,97 mld. | |
+5,41% | 3,31 mld. | |
-21,39% | 2,76 mld. | |
-11,93% | 2,26 mld. | |
+44,07% | 1,92 mld. | |
-17,86% | 1,5 mld. | |
+43,25% | 1,48 mld. | |
-9,38% | 1,49 mld. |